Save time and get answers to complex questions with AI chat
How much is mebendazole?How does iron rich food intake impact lipitor's efficacy?What excipients are combined with ruxolitinib in apotex's medication?Sun pharma bortezomib?Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?
See the DrugPatentWatch profile for keytruda
Keytruda (pembrolizumab) received its initial FDA approval on March 4, 2014, for unresectable or metastatic melanoma.
Other Questions About Keytruda :